Healthcare & Life Sciences
R5 Pharmaceuticals Limited
United Kingdom
acquiredacquired
acquired
Stage
About
R5 Pharmaceuticals Limited operated a sterile facility at BioCity in Nottingham, providing clinical trial services to drug manufacturers as a contract research organisation (CRO). It was funded by Catapult Ventures and was acquired by Aesica in 2010.
Explore R5 Pharmaceuticals Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.